Pacer Advisors
ALT icon

Pacer Advisors’s Altimmune ALT Stock Holding History

Pacer Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
+3,759
New +$11.2K ﹤0.01% 2338
2024
Q3 		– Sell
-1,260
Closed -$8.38K – 2562
2024
Q2 		$8.38K Sell
1,260
-2,899
-70% -$21.4K ﹤0.01% 3580
2024
Q1 		$42.3K Buy
+4,159
New +$42.3K ﹤0.01% 3234
2021
Q2 		– Sell
-4,650
Closed -$66K – 1411
2021
Q1 		$66K Buy
+4,650
New +$75.2K ﹤0.01% 1394

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacer Advisors's ALT Position: Q2 2026 in Review

Pacer Advisors opened a new position in Altimmune (ALT) in Q2 2026: 3,759 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2338 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in ALT as recently as Q2 2024.

Pacer Advisors first reported a position in ALT in Q1 2021 and has held it in 4 quarters since. The position peaked at $66K in Q1 2021. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Pacer Advisors held 3,759 shares of Altimmune worth $11K as of Q2 2026.
  • Altimmune was a new Pacer Advisors position in Q2 2026.
  • Altimmune made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2338 holding.
  • Pacer Advisors first reported a position in Altimmune in Q1 2021 and has held it in 4 quarters since.
  • Pacer Advisors's Altimmune position peaked at $66K in Q1 2021.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.